This publication, Comprehensive cervical cancer control: a guide to essential practice (C4GEP), gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and control, and highlights the need for collaboration across programmes, organizations and partners. This new guide updates the 2006 edition and includes the recent promising developments in technologies and strategies that can address the gaps between the needs for and availability of services for cervical cancer prevention and control.

Contents

• Acknowledgements
• Acronyms and abbreviations
• Compilation of key points
• Preface
• Introduction
• 1. Background
  • About this chapter
  • 1.1 Why focus on cervical cancer?
  • 1.2 Female pelvic anatomy and physiology
  • 1.3 Natural history of cancer of the cervix
  • Further reading
• 2. Essentials for cervical cancer prevention and control programmes
  • About this chapter
  • 2.1 What is a comprehensive cervical cancer prevention and control programme?
  • 2.2 National cervical cancer prevention and control programmes
  • 2.3 Achieving cervical cancer prevention and control
  • Further reading
• 3. Community mobilization, education and counselling
  • About this chapter
  • 3.1 Increasing the use of cervical cancer prevention and control services
  • 3.2 Outreach
  • 3.3 Community mobilization
  • 3.4 Preventive health education
  • 3.5 Counselling
  • Further reading
• 4. HPV vaccination
  • About this chapter
  • 4.1 Roles of health-care providers and others
  • 4.2 HPV vaccines
  • 4.3 Target population and delivery strategies
  • 4.4 Community mobilization
  • 4.5 Obtaining consent/assent for a girl to get vaccinated
  • 4.6 Monitoring and evaluation and sustainability of HPV vaccination programmes
  • Further reading
• 5. Screening and treatment of cervical pre-cancer
  • About this chapter
  • 5.1 Health-care providers
  • 5.2 Cervical cancer screening
  • 5.3 Screening methods for cervical pre-cancer
  • 5.4 Diagnostic tests for detection of cervical pre-cancer
  • 5.5 Treatment options for cervical pre-cancer
  • 5.6 Possible complications and follow-up after treatment
  • 5.7 Linking screening and treatment in practice
• 6. Diagnosis and treatment of invasive cervical cancer
  • About this chapter
  • 6.1 Presentation and diagnosis of cervical cancer
  • 6.2 The role of the health-care provider
  • 6.3 Cervical cancer staging
  • 6.4 Treatment of invasive cervical cancer: overview
  • 6.5 Treatment options
  • 6.6 Special situations: cervical cancer in pregnancy and in women living with HIV
  • 6.7 Patient support and follow-up
  • Further reading
• 7. Palliative care
  • About this chapter
  • 7.1 A comprehensive approach to palliative care
  • 7.2 The role of the family in palliative care
  • 7.3 The roles of health-care providers
  • 7.4 Managing common symptoms in advanced cervical cancer
  • 7.5 Keeping the patient and her support circle informed
  • Further reading
• Practice sheets
• Annex 1 Lists of participants and contributors
• Annex 2 Guideline development methodology, roles of the technical and working groups, and management and declarations of conflicts of interest
• Annex 3 Infection prevention and control
• Annex 4 Cancer and pre-cancer classification systems
• Annex 5 The 2001 Bethesda System
• Annex 6 HPV immunization sample forms
• Annex 7 Decision-making flowchart for screen-and-treat strategies
• Annex 8 Flowcharts for screen-and-treat strategies (negative or unknown HIV status)
• Annex 9 Flowcharts for screen-and-treat strategies (HIV-positive status or unknown HIV status in areas with high endemic HIV infection)
• Annex 10 Cervical cancer treatment by FIGO stage
• Annex 11 Sample documents
• Annex 12 Treatment of cervical infections and pelvic inflammatory disease (PID)
• Annex 13 How to make Monsel's paste
• Annex 14 Pathology reporting for cervical carcinoma
• Glossary

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.